Pharmaceuticals

Global Tumor Infiltrating Lymphocytes Market Overview: Trends Shaping Growth to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Tumor Infiltrating Lymphocytes Industry By The Forecast Year 2029?

The tumor infiltrating lymphocytes market has seen considerable expansion in recent years. Its value is expected to rise from $10.6 billion in 2024 to $12.05 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.6%. This historical growth can be linked to several factors, including a rise in cancer cases, increased research investment, regulatory clearances, heightened public awareness, and proven clinical success and efficacy.

The tumor infiltrating lymphocytes market is anticipated to show significant expansion in the coming years, projected to reach “$20.41 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.1%. This growth during the forecast period can be attributed to several factors including pipeline developments, rising healthcare expenditure, the emergence of new markets, strategic alliances, favorable regulatory support, and increasing patient demand. Key trends influencing this period encompass advancements in immunotherapy, intensified research and development initiatives, the evolving regulatory landscape, the growth of personalized medicine, and increasing market competition.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9440&type=smp

What Are The Top Growth Drivers Impacting The Tumor Infiltrating Lymphocytes Market Outlook?

The increasing prevalence of cancer patients is anticipated to drive the expansion of the tumor infiltrated lymphocytes (TIL) market moving ahead. Cancer is characterized by the uncontrolled proliferation and dissemination of certain body cells, resulting in various, potentially fatal, health complications. Tumor-infiltrating lymphocytes are immune cells capable of identifying and eliminating cancerous cells. These lymphocytes are isolated from a patient’s tumor, massively expanded in vitro, and then re-infused to bolster the immune system’s fight against cancer. For example, a report from the Australian Institute of Health and Welfare in August 2024 indicated that Australia is forecast to experience around 209,000 new cancer diagnoses by 2034, an increase from the projected 169,000 cases in 2024, attributed to population growth and increasing cancer incidence. Furthermore, in 2024, cancer is expected to be responsible for approximately 3 out of every 10 fatalities nationwide. Consequently, the growing number of cancer patients is set to fuel the tumor infiltrated lymphocyte market.

Which Key Segments Fueling The Tumor Infiltrating Lymphocytes Market?

The tumor infiltrating lymphocytes market covered in this report is segmented –

1) By Anatomy: CD3, CD8, CD16, CD56, CD4, CD57, CD169, CD68, FOXP3

2) By Component: T-Cells, B-Cells, Natural Killer Cells

3) By Application: Melanoma, Cervical Cancer, Ovarian Cancer, Other Applications

4) By End-User: Hospitals, Cancer Research Centers, Clinics

Subsegments:

1) By CD3: T-Cell Activation Markers

2) By CD8: Cytotoxic T Cells

3) By CD16: Natural Killer (NK) Cells

4) By CD56: NK Cell Markers

5) By CD4: Helper T Cells

6) By CD57: Senescent T Cells

7) By CD169: Macrophage Activation

8) By CD68: Macrophage Markers

9) By FOXP3: Regulatory T Cells (Tregs)

What Trends Are Expected To Drive The Tumor Infiltrating Lymphocytes Market?

Technological advancements are emerging as a crucial trend gaining traction in the tumor infiltrating lymphocytes market. Major companies operating in the tumor-infiltrating lymphocytes market are focusing on developing technologically advanced solutions to strengthen their market position. For instance, in May 2022, Obsidian Therapeutics Inc, a US-based biotechnology firm that develops engineered tumor-infiltrating lymphocytes (TIL cells) and gene treatments, announced the launch of cytoDRIVE technology. The data from this new technology demonstrates precise control over the timing and level of protein activity using FDA-approved small chemicals. Utilizing powerful cytokines like IL12 to support cell treatments represents a potential method for addressing solid cancers. The findings reveal that numerous cytokines, including IL12, IL23, IL2, and IFN, can be robustly and reversibly regulated, potentially allowing for their safe use in adoptive cell therapy applications.

Which Major Industry Participants Are Leading The Tumor Infiltrating Lymphocytes Market Growth?

Major companies operating in the tumor infiltrating lymphocytes market include Novartis AG, Pfizer Inc., Precision BioScience Inc., TCR2 Therapeutics Inc., Merck KGaA, Autolus Therapeutics PLC., Eli Lilly and Company, Oxford Biomedica PLC., Unum Therapeutics Inc., Amgen Inc., Gilead Sciences Inc., Sorrento Therapeutics Inc., TILT Biotherapeutics Ltd., Iovance Biotherapeutics Inc., Adaptimmune Therapeutics plc, Atara Biotherapeutics Inc., BioNTech SE, CARsgen Therapeutics Ltd., Cellectis S.A., Celyad Oncology SA, CRISPR Therapeutics AG, Intellia Therapeutics Inc., MaxCyte Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/tumor-infiltrating-lymphocytes-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Tumor Infiltrating Lymphocytes Market?

North America was the largest region in the tumor infiltrating lymphocytes market in 2024. The regions covered in the tumor infiltrating lymphocytes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Tumor Infiltrating Lymphocytes Market Report:

https://www.thebusinessresearchcompany.com/customise?id=9440&type=smp

Browse Through More Reports Similar to the Global Tumor Infiltrating Lymphocytes Market 2025, By The Business Research Company

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Tumor Ablation Therapy Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795